738
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

LncRNA USP2-AS1 facilitates the osteogenic differentiation of bone marrow mesenchymal stem cells by targeting KDM3A/ETS1/USP2 to activate the Wnt/β-catenin signaling pathway

, , , , , & show all
Pages 1-13 | Accepted 10 Aug 2023, Published online: 22 Dec 2023

References

  • Dragojevič J, Logar DB, Komadina R, et al. Osteoblastogenesis and adipogenesis are higher in osteoarthritic than in osteoporotic bone tissue. Arch Med Res. 2011;42(5):392–7. doi: 10.1016/j.arcmed.2011.08.005
  • Yang X, Yang J, Lei P, et al. LncRNA MALAT1 shuttled by bone marrow-derived mesenchymal stem cells-secreted exosomes alleviates osteoporosis through mediating microRNA-34c/SATB2 axis. Aging. 2019;11(20):8777–91. doi: 10.18632/aging.102264
  • Huang Y. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cellular Molecular Medi. 2018;22(12):5768–75. doi: 10.1111/jcmm.13866
  • Tye CE, Boyd JR, Page NA, et al. Regulation of osteogenesis by long noncoding RNAs: an epigenetic mechanism contributing to bone formation. Connect Tissue Res. 2018;59(sup1):35–41.
  • Zheng S, Wang YB, Yang YL, et al. LncRNA MALAT1 inhibits osteogenic differentiation of mesenchymal stem cells in osteoporosis rats through MAPK signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(11):4609–17.
  • Shi ZL, Zhang H, Fan ZY, et al. Long noncoding RNA LINC00314 facilitates osteogenic differentiation of adipose-derived stem cells through the hsa-miR-129-5p/GRM5 axis via the Wnt signaling pathway. Stem Cell Res Ther. 2020;11(1):240.
  • Wu H, Cao F, Zhou W, et al. Long noncoding RNA FAM83H-AS1 modulates SpA-Inhibited osteogenic differentiation in human bone mesenchymal stem cells. Mol Cell Biol. 2020;40(5):40.
  • Li D, Bao J, Yao J, et al. lncRNA USP2-AS1 promotes colon cancer progression by modulating Hippo/YAP1 signaling. Am J Transl Res. 2020;12(9):5670–82.
  • Guo B, Yu L, Sun Y, et al. Long non-coding RNA USP2-AS1 accelerates cell proliferation and migration in ovarian cancer by sponging miR-520d-3p and up-regulating KIAA1522. CMAR. 2020;12:10541–50. doi: 10.2147/CMAR.S268863
  • Baek D, Park KH, Lee KM, et al. Ubiquitin-specific protease 53 promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Cell Death Dis. 2021;12(3):238.
  • Kong X, Duan Y, Sang Y, et al. LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215. J Cell Physiol. 2019;234(6):9105–17.
  • He J, Yu J. Long noncoding RNA FAM83A-AS1 facilitates hepatocellular carcinoma progression by binding with NOP58 to enhance the mRNA stability of FAM83A. Biosci Rep. 2019;39(11):39. doi: 10.1042/BSR20192550
  • Pan L, Li Y, Jin L, et al. TRPM2-AS promotes cancer cell proliferation through control of TAF15. Int J Biochem Cell Biol. 2020;120:105683. doi: 10.1016/j.biocel.2019.105683
  • Yang T, Chen WC, Shi PC, et al. Long noncoding RNA MAPKAPK5-AS1 promotes colorectal cancer progression by cis-regulating the nearby gene MK5 and acting as a let-7f-1-3p sponge. J Exp Clin Cancer Res. 2020;39(1):139.
  • Jia B, Wang Z, Sun X, et al. Long noncoding RNA LINC00707 sponges miR-370-3p to promote osteogenesis of human bone marrow-derived mesenchymal stem cells through upregulating WNT2B. Stem Cell Res Ther. 2019;10(1):67. doi: 10.1186/s13287-019-1161-9
  • Liu J, Wu M, Feng G, et al. Downregulation of LINC00707 promotes osteogenic differentiation of human bone marrow‑derived mesenchymal stem cells by regulating DKK1 via targeting miR‑103a‑3p. Int J Mol Med. 2020;46(3):1029–38. doi: 10.3892/ijmm.2020.4672
  • Zhang Y, Huang YX, Wang DL, et al. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network. Theranostics. 2020;10(23):10823–37.
  • Deng SJ, Chen HY, Ye Z, et al. Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. Oncogene. 2018;37(44):5811–28.
  • Gong J, Fan H, Deng J, et al. LncRNA HAND2-AS1 represses cervical cancer progression by interaction with transcription factor E2F4 at the promoter of C16orf74. J Cellular Molecular Medi. 2020;24(11):6015–27. doi: 10.1111/jcmm.15117
  • Zheng S, Yang L, Zou Y, et al. Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer. J Hematol Oncol. 2020;13(1):17.
  • Ma Y, Jin Y, Li C, et al. LncRNA MSC-AS1 motivates the development of melanoma by binding to miR-302a-3p and recruiting IGF2BP2 to elevate LEF1 expression. Exp Dermatol. 2021;30(12):1764–74. doi: 10.1111/exd.14427
  • Zhang Y, Chen W, Pan T, et al. LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous cell carcinoma by interacting with HNRNPC to enhance the stability of ZEB1 and ZEB2 mRnas. Biochem Biophys Res Commun. 2019;511(3):566–72. doi: 10.1016/j.bbrc.2019.02.079
  • Fan X, Teng Y, Ye Z, et al. The effect of gap junction-mediated transfer of miR-200b on osteogenesis and angiogenesis in a co-culture of MSCs and HUVECs. J Cell Sci. 2018;131. doi: 10.1242/jcs.216135
  • Zhang W, Zhu Y, Chen J, et al. Mechanisms of miR‑128‑3p in inhibiting osteoblast differentiation from bone marrow‑derived mesenchymal stromal cells. Mol Med Rep. 2020;22(6):5041–52. doi: 10.3892/mmr.2020.11600
  • Park KH, Choi Y, Yoon DS, et al. Zinc promotes osteoblast differentiation in human mesenchymal stem cells via activation of the cAMP-PKA-CREB signaling pathway. Stem Cells Dev. 2018;27(16):1125–35. doi: 10.1089/scd.2018.0023
  • Zhang X, Chen J, Liu A, et al. Stable overexpression of p130/E2F4 affects the multipotential abilities of bone-marrow-derived mesenchymal stem cells. J Cell Physiol. 2018;233(12):9739–49.
  • Wang Q, Cai J, Cai XH, et al. miR-346 regulates osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting the Wnt/β-catenin pathway. PLoS One. 2013;8(9):e72266. doi: 10.1371/journal.pone.0072266
  • Piek E, Sleumer LS, van Someren EP, et al. Osteo-transcriptomics of human mesenchymal stem cells: accelerated gene expression and osteoblast differentiation induced by vitamin D reveals c-MYC as an enhancer of BMP2-induced osteogenesis. Bone. 2010;46(3):613–27.
  • Sobral LM, Sechler M, Parrish JK, et al. KDM3A/Ets1/MCAM axis promotes growth and metastatic properties in Rhabdomyosarcoma. Genes Cancer. 2020;11(1–2):53–65.
  • Sobral LM, Hicks HM, Parrish JK, et al. KDM3A/Ets1 epigenetic axis contributes to PAX3/FOXO1-driven and independent disease-promoting gene expression in fusion-positive Rhabdomyosarcoma. Mol Oncol. 2020;14(10):2471–86.
  • Liu J, Li D, Zhang X, et al. histone demethylase KDM3A promotes cervical cancer malignancy through the ETS1/KIF14/Hedgehog axis. OTT. 2020;13:11957–73. doi: 10.2147/OTT.S276559
  • Wu JC, Sun J, Xu JC, et al. Down-regulated microRNA-199a-3p enhances osteogenic differentiation of bone marrow mesenchymal stem cells by targeting Kdm3a in ovariectomized rats. Biochem J. 2021;478(4):721–34. doi: 10.1042/BCJ20200314
  • Shen G, Ren H, Shang Q, et al. Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss. EBioMedicine. 2020;52:102626. doi: 10.1016/j.ebiom.2020.102626
  • Hang K, Ye C, Xu J, et al. Apelin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells partly through Wnt/β-catenin signaling pathway. Stem Cell Res Ther. 2019;10(1):189.
  • Fan T, Qu R, Yu Q, et al. Bioinformatics analysis of the biological changes involved in the osteogenic differentiation of human mesenchymal stem cells. J Cellular Molecular Medi. 2020;24(14):7968–78.
  • Yang Q, Jia L, Li X, et al. Long noncoding RNAs: new players in the osteogenic differentiation of bone marrow- and adipose-derived mesenchymal stem cells. Stem Cell Rev and Rep. 2018;14(3):297–308.
  • Tang JZ, Zhao GY, Zhao JZ, et al. lncRNA IGF2-AS promotes the osteogenic differentiation of bone marrow mesenchymal stem cells by sponging miR-3,126-5p to upregulate KLK4. J Gene Med. 2021;23(10):e3372. doi: 10.1002/jgm.3372
  • Chen X, Yang L, Ge D, et al. Long non‑coding RNA XIST promotes osteoporosis through inhibiting bone marrow mesenchymal stem cell differentiation. Exp Ther Med. 2019;17:803–11. doi: 10.3892/etm.2018.7033
  • He J, Lee HJ, Saha S, et al. Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy. Cell Death Dis. 2019;10(4):285. doi: 10.1038/s41419-019-1512-6
  • Long X, Song K, Hu H, et al. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis. J Exp Clin Cancer Res. 2019;38(1):345.
  • Xu H, Zhao G, Zhang Y, et al. Long non-coding RNA PAXIP1-AS1 facilitates cell invasion and angiogenesis of glioma by recruiting transcription factor ETS1 to upregulate KIF14 expression. J Exp Clin Cancer Res. 2019;38(1):486.
  • Almalki SG, Agrawal DK. Key transcription factors in the differentiation of mesenchymal stem cells. Differentiation. 2016;92(1–2):41–51. doi: 10.1016/j.diff.2016.02.005
  • Fan Q, Li Y, Sun Q, et al. miR-532-3p inhibits osteogenic differentiation in MC3T3-E1 cells by downregulating ETS1. Biochem Biophys Res Commun. 2020;525(2):498–504. doi: 10.1016/j.bbrc.2020.02.126
  • Cai WL, Zeng W, Liu HH, et al. LncRNA LINC00707 promotes osteogenic differentiation of hBmscs through the Wnt/β-catenin pathway activated by LINC00707/miR-145/LRP5 axis. Eur Rev Med Pharmacol Sci. 2020;24(1):18–28. doi: 10.26355/eurrev_202001_19891